{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T12:10:03Z","timestamp":1772712603457,"version":"3.50.1"},"reference-count":86,"publisher":"Informa UK Limited","issue":"23","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biomolecular Structure and Dynamics"],"published-print":{"date-parts":[[2022,12,19]]},"DOI":"10.1080\/07391102.2021.1973910","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T07:29:12Z","timestamp":1631518152000},"page":"12621-12641","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Finding a prospective dual-target drug for the treatment of coronavirus disease by theoretical study"],"prefix":"10.1080","volume":"40","author":[{"given":"Karim","family":"Mahnam","sequence":"first","affiliation":[{"name":"Department of Biology, Faculty of Sciences, Shahrekord University","place":["Shahrekord, Iran"]},{"name":"Nanotechnology Research Center, Shahrekord University, Shahrekord, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Ghobadi","sequence":"additional","affiliation":[{"name":"Department of Biology, Faculty of Sciences, Shahrekord University","place":["Shahrekord, Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11224-020-01586-w"},{"issue":"11","key":"e_1_3_3_3_1","first-page":"1","article-title":"Quinolines-based SARS-CoV-2 CLpro and RdRp inhibitors and spike-RBD-ACE2 inhibitor for drug-repurposing against COVID-19: An in silico analysis","volume":"23","author":"Alexpandi R.","year":"2020","unstructured":"Alexpandi, R., De Mesquita, J. F., Pandian, S. K., & Ravi, A. V. (2020). Quinolines-based SARS-CoV-2 CLpro and RdRp inhibitors and spike-RBD-ACE2 inhibitor for drug-repurposing against COVID-19: An in silico analysis. Frontiers in Microbiology, 23(11), 1\u201315.","journal-title":"Frontiers in Microbiology"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.34172\/PS.2021.3"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja8085643"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2020.100721"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2020.128595"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14060503"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1063\/1.448118"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77700-z"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200201000-00003"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02355-3"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.05.019"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20290"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2020.198146"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2021.1901144"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1063\/1.464397"},{"key":"e_1_3_3_18_1","first-page":"1, 1","article-title":"Thalidomide against coronavirus disease 2019 (COVID-19): A medicine with a thousand faces","volume":"19","author":"Dastan F.","year":"2020","unstructured":"Dastan, F., Tabarsi Payam, P., Marjani, M., Moniri, A., Hashemian, S. M. R., Tavakoli-Ardakani, M., & Saffaei, A. (2020). Thalidomide against coronavirus disease 2019 (COVID-19): A medicine with a thousand faces. Iranian Journal of Pharmaceutical Research, 19, 1, 1\u20132.","journal-title":"Iranian Journal of Pharmaceutical Research"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.5812\/archcid.13823"},{"key":"e_1_3_3_20_1","doi-asserted-by":"crossref","unstructured":"de Oliveira M. D. L. & Oliveira K. (2020). Comparative docking of SARS-CoV-2 receptors antagonists from repurposing drugs. https:\/\/www.researchgate.net\/publication\/340389889","DOI":"10.26434\/chemrxiv.12044538.v4"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/071102.2020.1772885"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-021-00238-y"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.592908"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105960"},{"issue":"1","key":"e_1_3_3_25_1","first-page":"173","article-title":"Molecular dynamics and docking investigations of several zoanthamine-type marine alkaloids as matrix metaloproteinase-1 inhibitors","volume":"16","author":"Farrokhnia M.","year":"2017","unstructured":"Farrokhnia, M., & Mahnam, K. (2017). Molecular dynamics and docking investigations of several zoanthamine-type marine alkaloids as matrix metaloproteinase-1 inhibitors. Iranian Journal of Pharmaceutical Research, 16(1), 173\u2013186.","journal-title":"Iranian Journal of Pharmaceutical Research"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102180"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.8b00312"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1039\/D0RA05434H"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.10379"},{"issue":"3","key":"e_1_3_3_30_1","first-page":"209","article-title":"Strategy of molecular drug design: Dual-target drug design","volume":"44","author":"Guo Z. R.","year":"2009","unstructured":"Guo, Z. R. (2009). Strategy of molecular drug design: Dual-target drug design. Yao Xue Xue Bao\u2009=\u2009Acta Pharmaceutica Sinica, 44(3), 209\u2013218. Article in Chinese.","journal-title":"Yao Xue Xue Bao\u2009=\u2009Acta Pharmaceutica Sinica"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.0c00161"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12088-020-00857-8"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01896.x"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06387"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jpclett.0c00994"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1791958"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1063\/1.445869"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051473"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-015-0218-9"},{"issue":"1","key":"e_1_3_3_40_1","first-page":"9","article-title":"Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza","volume":"44","author":"Kimberly E.","year":"2019","unstructured":"Kimberly, E. (2019). Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza. P & T, 44(1), 9\u201311.","journal-title":"P & T"},{"issue":"6","key":"e_1_3_3_41_1","first-page":"9","article-title":"A new antiviral drug Triazavirin: Results of phase II clinical trial","volume":"57","author":"Kiselev O. I.","year":"2012","unstructured":"Kiselev, O. I., Deeva, E. G., Mel'nikova, T. I., Kozeletskaia, K. N., Kiselev, A. S., Rusinov, V. L., Charushin, V. N., & Chupakhin, O. N. (2012). A new antiviral drug Triazavirin: Results of phase II clinical trial. Voprosy Virusologii, 57(6), 9\u201312.","journal-title":"Voprosy Virusologii"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74099-5"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115438"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104425"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13337-020-00643-6"},{"issue":"92","key":"e_1_3_3_46_1","first-page":"91","article-title":"Umifenovir and coronavirus infections: A review of research results and clinical practice","volume":"26","author":"Leneva I. A.","year":"2020","unstructured":"Leneva, I. A., Pshenichnaya, N. Y., & Bulgakova, V. A. (2020). Umifenovir and coronavirus infections: A review of research results and clinical practice. Ter Arkh, 26(92(11), 91\u201397. Russian.","journal-title":"Ter Arkh"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.26.009803"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.5b00255"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph13080188"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2018.00007"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu13030812"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S254754"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1768151"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom11070919"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8101600"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1751291"},{"key":"e_1_3_3_57_1","first-page":"2","article-title":"Mild COVID-19 infection in a patient with multiple sclerosis, while taking fingolimod: A case report","volume":"12","author":"Mohammadpour M.","year":"2021","unstructured":"Mohammadpour, M., Fattahi, M. R., Sahraian, M. A., Moghadasi, A. N., & Navardi, S. (2021). Mild COVID-19 infection in a patient with multiple sclerosis, while taking fingolimod: A case report. Journal of Neurology and Neuroscience, 12, 2.","journal-title":"Journal of Neurology and Neuroscience"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2021946118"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.7326\/M21-0653"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2008.07.030"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2020.107716"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2020.107769"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.636362"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21372"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0397-341"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1021\/ct400341p"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2021.1925293"},{"key":"e_1_3_3_68_1","unstructured":"Sahoo S. K. & Vardhan S. (2020). Computational evidence on repurposing the anti-influenza drugs baloxavir acid and baloxavir marboxil against COVID-19. https:\/\/arxiv.org\/abs\/2009.01094."},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1021\/ct400314y"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-019-1182-0"},{"key":"e_1_3_3_71_1","doi-asserted-by":"crossref","unstructured":"Sheybani Z. Dokoohaki M. H. Negahdaripour M. Dehdashti M. Zolghadr H. & Moghadami M. (2020). The role of folic acid in the management of respiratory disease caused by COVID-19. ChemRxiv. Cambridge Open Engage.","DOI":"10.26434\/chemrxiv.12034980.v1"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S81934"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.06.063"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1242\/bio.054056"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21334"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1139\/cjpp-2020-0734"},{"key":"e_1_3_3_77_1","doi-asserted-by":"crossref","unstructured":"Unni S. Aouti S. & Padmanabhan B. (2020). Identification of a potent inhibitor targeting the spike protein of pandemic human coronavirus SARS-CoV-2 by computational methods. ChemRxiv. Cambridge Open Engage.","DOI":"10.26434\/chemrxiv.12197934.v1"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110668"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/8.2.127"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.9b00055"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20035"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-1280(00)00487-5"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eng.2020.08.011"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.3390\/v13010109"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53945-1"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072657"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.theochem.2004.04.065"}],"container-title":["Journal of Biomolecular Structure and Dynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/07391102.2021.1973910","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T11:11:51Z","timestamp":1772709111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/07391102.2021.1973910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":86,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2022,12,19]]}},"alternative-id":["10.1080\/07391102.2021.1973910"],"URL":"https:\/\/doi.org\/10.1080\/07391102.2021.1973910","relation":{},"ISSN":["0739-1102","1538-0254"],"issn-type":[{"value":"0739-1102","type":"print"},{"value":"1538-0254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=tbsd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=tbsd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-04-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}